Subject Registrations Adverse Events Subject Registrations Biospecimens Lab Results IN: 1. Lab Results OUT: 1. Subject Registrations 2. Clinical Notes 3. Adverse Events 4. Biospecimens 5. Lab Results Arrays 1. Arrays 2. Image 1. Register Subjects 2. Track Subject Activities 3. Report Adverse Events 4. Reports 1. Analyze Trial Data 1. Collect & Track Biospecimens 1. Finalize AE 2. Report Serious AE caGrid Registration Consumer [1B] AE Service [2A] caBIG Integration Hub (ESB) caTissue Service [1D, 3C] Semantic Infrastructure caArray Service [TBD] caAERS [3A] caArray [1D?] caIntegrator [1D, 2E, 3B, 3E] Tolven (CDMS) Web Applications Infrastructure Services & API CCHC (EMR) [1C] RIM/CDA Service (EMR) [1A] Clinical Notes (CDA) caTissue [1D, 3C] 1. Conduct Array Experiments EMRs (Trial Sites) 1. Patient Clinical Care caBIG Services caBIG Web Applications Trial Sites iSPY2 Trial Users caAERS, EMR & caIntegrator WebSSO (Single Sign On) NBIA [2D] PRO CTCAE [2C] ACRIN NBIA Service [2D] Image 1. Input Image Information Patients 1. Report Outcomes 1. Terminologies 2. Common Data Elements

White Paper Section Requirement 1A Integration of TRANSCEND with electronic health record systems (EHRs) systems using an HL-7 based messaging. At a minimum, allow TRANSCEND (Tolven) to "push" a clinical note record to the local EHR for inclusion in the patient's institutional record. 1B Automated integration of trial participant information into local institutional Clinical Trial Management Systems (CTMS) and regulatory systems. 1C Automated integration of TRANSCEND with Laboratory Information Systems (LISs) for laboratory data coming from each study site’s local clinic. 1D Integration between TRANSCEND and local bio-repositories for managing the processing and reporting of experimental assays using study bio-specimens. 2A Automated integration of trial data with an adverse event reporting system through an enhanced data exchange interface. 2B Web-based patient communication and care plan that integrate the trial schedule, including treatment and procedures, into a personal calendar.. (Not represented on architecture chart.) 2C Web interface for trial patients to report side effects they are experiencing while on treatment. 2D Adopt and integrate additional imaging tools that annotate and track lesions identified by MRI and other imaging platforms. 2E Improve automated trial administrative capabilities within TRANSCEND that include analytic tools.

White Paper Section Requirement 3A Developing analytical functionality within an Adverse Event Report System 3B Improve trial data portal (i.e. caIntegrator) to enable specifying a user’s access to limited trial data. 3C Improve electronic bio-specimen repository system to allow for user expansion of additional types of bio-specimens collected and develop better analytical and quality management functions. 3D Enhance TRANSCEND functionality so current HL7 coded trial data can map to CDIS semantics. (Not represented on architecture chart.) 3E Enhance trial data portal to increase the traceability and reproducibility of statistical analysis that is done with trial data. 3F Enhance ability to capture structured clinical data through "XML EDC Forms“. (Not represented on architecture chart.)